Type of steatosis influences microcirculation and fibrogenesis in different rat strains

Journal of Investigative Surgery

Volumn 24, Issue 6, 2011, Pages 273-282

  Rosenstengel, Stephan ^a   Stoeppeler, Sandra ^a   Bahde, Ralf ^a   Spiegel, Hans Ullrich ^a   Palmes, Daniel ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Intravital microscopy; Light microscopy; Nonalcoholic fatty liver disease (NAFLD); Rat strain; Steatosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CELL DENSITY; CENTRAL VEIN; CLINICAL FEATURE; CONTROLLED STUDY; FIBROGENESIS; LEWIS RAT; LIPID DIET; LIVER CELL; LIVER FIBROSIS; LIVER SINUSOID; MALE; MICROCIRCULATION; MICROSCOPY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT; STELLATE CELL; WISTAR RAT;

ANIMALS; DIET, HIGH-FAT; FATTY LIVER; FIBROSIS; LIVER; LIVER CIRRHOSIS; MALE; MICROCIRCULATION; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 80455174348     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2011.586094     Document Type: Article

References (30)

1. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710-723.
2. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40:1387-1395.
3. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during followup in an Italian population. Dig Dis Sci. 1997;42:1428-1432.
4. Matteoni CA, Younossi ZM,Gramlich T, et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
5. Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005;15:310-315.
6. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140.
7. Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-1354.
8. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998;114:842-845.
9. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.
10. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-923.
11. Bugianesi E, Zannoni C, Vanni E, et al. Non-alcoholic fatty liver and insulin resistance: A cause-effect relationship? Dig Liver Dis. 2003;36:165-173.
12. Albano E, Mottaran E, Occhino G, et al. Review article: Role of oxidative stress in the progression of non-alcoholic steatosis. Aliment Pharmacol Ther. 2005;22:71-73.
13. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-443.
14. Majno G. The story of the myofibroblasts. Am J Surg Pathol. 1979;3:535-542.
15. Day CP. From fat to inflammation. Gastroenterology 2006;130:207-210.
16. Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec. 2008;291:684-692.
17. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis. 2001;21:89-104.
18. Ip E, Farrell GC, Robertson G, et al. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003;38:123-132.
19. Leclercq IA, Farrell GC, Schriemer R, et al. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002;37:206-213.
20. Lieber CS, Leo MA, Mak KM, et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 2003;79:502-509.
21. Uhlmann S, Uhlmann D, Spiegel HU. Evaluation of hepatic microcirculation by in vivo microscopy. J Invest Surg. 1999;12:179-193.
22. Budny T, Palmes D, Stratmann U, et al. Morphologic features in the regenerating liver-A comparative intravital, lightmicroscopical and ultrastructural analysis with focus on hepatic stellate cells. Virchows Arch. 2007;451:781-791.
23. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
24. McCaskey RS, Ito Y, Robertson GR, et al.Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004;40:386-393.
25. Hasegawa T, Ito Y, Wijeweera J, et al. Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1385-G1395.
26. Thimgan MS, Yee HF Jr. Quantitation of rat hepatic stellate cell contraction: Stellate cells' contribution to sinusoidal resistance. Am J Physiol. 1999;277:G137-G143.
27. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001;35:297-306.
28. SpiegelHU, Uhlmann D, Uhlmann S. Controlled vasoregulation of postischemic liver microcirculation-A therapeutic approach. J Invest Surg. 2000;13:273-278.
29. Mabuchi A, Mullaney I, Sheard PW, et al. Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat. J Hepatol. 2004;40:910-916.
30. Palmes D, Minin E, Budny T, et al. The endothelin/nitric oxide balance determines small-for-size liver injury after reduced-size rat liver transplantation. Virchows Arch. 2005;447:731-741.